Gainers
- Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares surged 159.9% to $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain. Concurrently, Avenue Therapeutics announced that it would effect a 1-for-15 reverse stock split.
- PaxMedica, Inc. (NASDAQ:PXMD) jumped 53.5% to $3.33 as the company issued a corporate update after IPO. The company named Stephen D. Sheldon as CFO.
- Scienjoy Holding Corporation (NASDAQ:SJ) surged 33.4% to $2.2281 after declining 44% on Monday.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 28% to $6.54. InMed recently reported a FY22 net loss of $33.17 per share.
- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) jumped 24% to $1.2001. Bellerophon announced FDA acceptance of change to ongoing Phase 3 REBUILD study of INOpulse for the treatment of fibrotic interstitial lung disease.
- FingerMotion, Inc. (NASDAQ:FNGR) gained 23% to $0.9999 after rising around 20% on Monday.
- Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 21.6% to $2.48 after gaining over 11% on Monday.
- Grove Collaborative Holdings, Inc. (NYSE:GROV) shares climbed 21.3% to $3.5901. Grove Collaborative continued retail expansion with entry into thousands of more stores.
- Unico American Corporation (NASDAQ:UNAM) gained 20.8% to $1.5099.
- 9 Meters Biopharma, Inc. (NASDAQ:NMTR) rose 20.3% to $0.2490 after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
- Milestone Scientific Inc. (NASDAQ:MLSS) gained 20% to $0.8193.
- Avalon GloboCare Corp. (NASDAQ:AVCO) jumped 19.8% to $0.5271.
- Pyxis Oncology, Inc. (NASDAQ:PYXS) gained 19.8% to $2.30.
- Biocept, Inc. (NASDAQ:BIOC) gained 17.1% to $0.9368.
- Equillium, Inc. (NASDAQ:EQ) jumped 15.5% to $2.23. Equillium announced interim results from the Type B portion of the EQUALISE study evaluating itolizumab in patients with lupus nephritis (LN).
- Foghorn Therapeutics Inc. (NASDAQ:FHTX) rose 14.1% to $8.67.
- The Beauty Health Company (NASDAQ:SKIN) gained 12.6% to $11.71 after the company announced a $200 million buyback.
- Stryve Foods, Inc. (NASDAQ:SNAX) jumped 12% to $0.45.
- Skillz Inc. (NYSE:SKLZ) jumped 11.9% to $1.0750.
- Verve Therapeutics, Inc. (NASDAQ:VERV) gained 11.5% to $34.73.
- BitNile Holdings, Inc. (NYSE:NILE) rose 10.6% to $0.2047.
- CVR Energy, Inc. (NYSE:CVI) gained 8.2% to $27.65.
- BIT Mining Limited (NYSE:BTCM) rose 7.7% to $0.28 after declining around 9% on Monday.
- Novavax, Inc. (NASDAQ:NVAX) gained 7.5% to $20.28. Novavax announced an initial one million doses of Nuvaxovid are available for use in the UK.
Losers
- FedNat Holding Company (NASDAQ:FNHC) fell 19.9% to $0.18 after dropping over 15% on Monday.
- Eve Holding, Inc. (NYSE:EVEX) dropped 18% to $10.08. BLADE India signed non-binding order for up to 200 eVTOL vehicles from Eve Air Mobility.
- Polar Power, Inc. (NASDAQ:POLA) fell 15.2% to $2.68 after gaining around 25% on Monday.
- Avidity Biosciences, Inc. (NASDAQ:RNA) shares fell 14.9% to $15.95. The FDA has placed a partial clinical hold on new participant enrollment in Avidity Biosciences’ Phase 1/2 MARINA trial of AOC 1001 in adults with myotonic dystrophy type 1 (DM1).
- Evaxion Biotech A/S (NASDAQ:EVAX) fell 14.9% to $2.34. Evaxion Biotech recently announced it reached an important milestone announcing today that it had enrolled its first patient in the global phase 2b clinical trial of EVX-01.
- FaZe Holdings Inc. (NASDAQ:FAZE) dropped 14.2% to $12.66.
- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) shares fell 14.1% to $6.15. Kiora Pharmaceuticals said its stockholders authorized a reverse stock split of its common stock.
- SAI.TECH Global Corporation (NASDAQ:SAI) dropped 14.1% to $4.10.
- Midatech Pharma plc (NASDAQ:MTP) fell 14% to $2.2365.
- Minerva Surgical, Inc. (NASDAQ:UTRS) dipped 13.8% to $0.7320.
- Provident Financial Services, Inc. (NYSE:PFS) fell 12.5% to $20.27. Provident Financial Services and Lakeland Bancorp to merge in an all-stock transaction.
- 374Water, Inc. (NASDAQ:SCWO) dropped 12.1% to $3.03.
- Golden Sun Education Group Limited (NASDAQ:GSUN) fell 11.6% to $36.00.
- Kronos Worldwide, Inc. (NYSE:KRO) dropped 11.2% to $9.48. Barclays maintained Kronos Worldwide with an Underweight and lowered the price target from $15 to $8.
- Inpixon (NASDAQ:INPX) fell 10.4% to $0.1260. Inpixon shares jumped over 21% on Monday after the company announced it signed a definitive merger agreement with KINS Technology for KINS to acquire Inpixon's enterprise apps business.
- Ocular Therapeutix, Inc. (NASDAQ:OCUL) dropped 10.5% to $4.7250. Ocular Therapeutix announced interim 7-month data from its U.S. Phase 1 trial evaluating OTX-TKI for wet age-related macular degeneration (wet AMD) and other retinal diseases.
- AMTD Digital Inc. (NYSE:HKD) shares fell 8.9% to $59.22.
- Troika Media Group, Inc. (NASDAQ:TRKA) shares fell 8.5% to $0.3453 after declining 6% on Monday.
- HeartCore Enterprises, Inc. (NASDAQ:HTCR) dropped 7.9% to $1.05.
- Studio City International Holdings Limited (NYSE:MSC) fell 6.9% to $2.28.
